Recently, GOLPH3 has been recognized as a new proto-oncogene, and overexpression of GOLPH3 has been observed in a variety of malignant tumors including ovarian cancer, breast cancer, prostate cancer, liver cancer, etc. [16,17]. This evidence concerns the gene GOLPH3 and breast cancer.